BioSig Technologies intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 10 pre-split shares. The reverse stock split will become effective at 4:05 p.m. New York Time on Thursday, February 1, 2024. BioSig’s common stock will continue to trade on the Nasdaq Capital Market under the symbol BSGM. It will begin trading on a split-adjusted basis when the market opens on Friday, February 2, 2024. The new CUSIP number for the common stock following the reverse stock split will be 09073N3008. At the Company’s annual meeting of stockholders held on December 18, 2023, BioSig’s stockholders granted the Company’s board of directors the discretion to effect a reverse stock split of all of the outstanding shares of the Company’s common stock through an amendment to its Amended and Restated Certificate of Incorporation at a ratio in the range of 1-for-2 to 1-for-10, with the exact exchange ratio and timing to be determined by the Company’s Board.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BSGM:
- BioSig Technologies Announces Strategic Workforce Reduction
- BioSig Technologies announces workforce reduction to decrease annual cash burn
- BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
- BioSig Technologies files $75M mixed securities shelf
- BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024